<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-143487</identifier>
<setSpec>0048-7120</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Effectiveness of electromyography-biofeedback in improving fecal incontinence and quality of life</dc:title>
<dc:description xml:lang="en">Introduction. Fecal incontinence (FI) is a clinical and social problem that affects health-related quality of life (QoL). The treatment of choice is conservative, with biofeedback being the most widely recommended. Objective. To determine the clinical/epidemiological variables related to FI and to assess the effectiveness of biofeedback with surface electrodes (EMG-BFB) in improving QoL in FI patients. Material and methods. A quasi-experimental prospective before/after FI study was conducted in 31 patients referred to the Rehabilitation Service of Salamanca between 2008 and 2014. The intervention consisted of 20 sessions of EMG-BFB twice weekly, supervised by a physiotherapist. Clinical and before and after QoL assessment was performed with the Wexner/FIQLS scale/questionnaire. Results. The mean age was 53 years, and 90.3% were women (female/male ratio, 9:1). Risk factors were an obstetric history of pregnancy/delivery (80.6%), dystocia (35.5%) and episiotomy (9.7%, P = .000), sphincter injury (38.7%), pelvic organ prolapse (35.5%, P = .000), connective tissue disease (19.4%, P = .05), colorectal (16.1%, P = .000) and urological (12.9%, P = .000) surgery. Associated neoplasms consisted of tumors of the cervix/uterus (12.9%, P = .000) and colon (6.5%, P = .026/P = .082). Severe FI was found in 67.75%, and double incontinence (fecal and urinary) in 61.3%. EMG-BFB significantly improved QoL in the Wexner/FIQLS Scale/Questionnaire (P &lt; .05). Conclusions. FI increases with age, is prevalent in women, and is associated specially with an obstetric history of pregnancy/delivery. FI is significantly associated with episiotomy, connective tissue disease, urological and colorectal surgery, neoplasms of the colon, uterus and cervix, and pelvic organ prolapse. EMG-BFB is effective in improving clinical symptoms and all components of QoL in patients with FI (AU)</dc:description>
<dc:creator>Alonso-Sardón, M</dc:creator>
<dc:creator>Pérez-Moro, O</dc:creator>
<dc:creator>Geanini-Yagüez, A</dc:creator>
<dc:creator>Mirón-Canelo, JA</dc:creator>
<dc:creator>Nieto-Blasco, J</dc:creator>
<dc:creator>Fernández-Cuadros, ME</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción. La incontinencia fecal (IF) supone un problema clínico y social que afecta la calidad de vida (CV). Su tratamiento de elección es conservador, y el biofeedback el más recomendado. Objetivo. Conocer las variables clínicas/epidemiológicas asociadas con la IF y valorar la efectividad de un protocolo de tratamiento de electromiografía-biofeedback (EMG-BFB) con electrodos de superficie en la mejora de la CV. Material y métodos. Estudio prospectivo tipo antes/después en 31 pacientes con IF remitidos al Servicio de Rehabilitación de Salamanca entre 2008 y 2014. El tratamiento consistió en 20 sesiones de EMG-BFB bisemanales supervisadas por fisioterapeuta. Se realizó una valoración clínica y de la CV inicial/final con la escala/cuestionario de Wexner/FIQLS. Resultados. Edad media 53 años, género femenino 90,3% (ratio mujer/hombre 9:1). Los factores de riesgo más frecuentes son: historia obstétrica de embarazo/parto (80,6%), distocia (35,5%) y episiotomía (9,7%, p = 0,000). Lesión de esfínteres (38,7%). Prolapso de órganos pélvicos (35,5%, p = 0,000). Enfermedad del tejido conectivo (19,4%, p = 0,05). Cirugía urológica (12,9%, p = 0,000) y colorrectal (16,1%, p = 0,000). Neoplasia asociadas: cérvix/útero (12,9%, p = 0,000), colon (6,5%, p = 0,026 antes, p = 0,082 después). IF grave (67,75%), doble incontinencia (fecal y urinaria) (61,3%). La EMG-BFB mejora la CV significativamente en la escala Wexner y el Cuestionario FIQLS (p &lt; 0,05). Conclusiones. La IF aumenta con la edad, prevalece en mujeres y se asocia fundamentalmente a historia obstétrica de embarazo/parto. Se asocia significativamente con la episiotomía, enfermedades del tejido conectivo, cirugía urológica/colorrectal, neoplasias de cérvix/útero/colon y prolapso de órganos pélvicos. La EMG-BFB constituye una técnica efectiva de tratamiento en los pacientes con IF, al mejorar la clínica y todos los componentes de CV del cuestionario/escala FIQLS/Wexner (AU)</dc:description>
<dc:source>Rehabilitación (Madr., Ed. impr.);49(4): 216-223, oct.-dic. 2015. tab, ilus</dc:source>
<dc:identifier>ibc-143487</dc:identifier>
<dc:title xml:lang="es">Efectividad del electromiografía- biofeedback en la incontinencia fecal y la calidad de vida</dc:title>
<dc:subject>^d5345^s22067</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d4648^s22048</dc:subject>
<dc:subject>^d4648^s22045</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d28608^s22074</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d5345^s22061</dc:subject>
<dc:subject>^d4648^s22039</dc:subject>
<dc:subject>^d5345^s29166</dc:subject>
<dc:subject>^d4648^s22066</dc:subject>
<dc:subject>^d4648^s22074</dc:subject>
<dc:subject>^d12225</dc:subject>
<dc:subject>^d54210^s22039</dc:subject>
<dc:subject>^d28607</dc:subject>
<dc:subject>^d4638^s22074</dc:subject>
<dc:type>article</dc:type>
<dc:date>201512</dc:date>
</metadata>
</record>
</ibecs-document>
